Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day

Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day

PR Newswire

BOSTON, Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at Citi's 2024 Unplugged Medtech and Life Sciences Access Day on Thursday, February 29, 2024 at 8:45 a.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://kvgo.com/unplugged-medtech-life-sciences-access-day/haemonetics-corp-feb-2024. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:


Olga Guyette, Sr. Director-Investor Relations & Treasury

David Trenk, Manager-Investor Relations

(781) 356-9763

(203) 733-4987

[email protected]

[email protected]



Media Contact:


Josh Gitelson, Director-Global Communications


(781) 356-9776


[email protected] 


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-citis-2024-unplugged-medtech-and-life-sciences-access-day-302068093.html

SOURCE Haemonetics Corporation

Copyright CNW Group 2024